System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland
IMPACT-CKD projects substantial increases in the multidimensional burdens of CKD in Switzerland. Impact could be mitigated via earlier detection and broader uptake of guideline-directed medical therapy. Comprehensive health policies and strategic public health planning are necessary to reduce burden and sustain Switzerland's 2050 net-zero healthcare ambition.
Authors
- Andrew M. Hall (ORCID: https://orcid.org/0000-0002-6328-7892)
- Giliane Nanchen
- George Wharton (ORCID: https://orcid.org/0000-0001-6544-3636)
- Stacey E. Priest
- Luke Hubbert
- Lindsay Nicholson (ORCID: https://orcid.org/0000-0001-5581-2792)
- Thomas Johannes Rosemann (ORCID: https://orcid.org/0000-0002-6436-6306)
- Stefan E. Buff
- Thomas Campbell-James
- A Zara
- Menno Pruijm
- Caterina Vecchio Rodriguez
Institutions
- Centre Hospitalier Universitaire Vaudois (CH)
- Kidney Care UK (GB)
- Zurich University of Teacher Education (CH)
- AstraZeneca (Switzerland) (CH)
- American Association of Kidney Patients (US)
- EVERSANA (Canada) (CA)
- London School of Economics and Political Science (GB)
- University of Lausanne (CH)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1007/s12325-026-03519-1
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität Zürich